STS database risk models: predictors of mortality and major morbidity for lung cancer resection
- PMID: 20732512
- DOI: 10.1016/j.athoracsur.2010.03.115
STS database risk models: predictors of mortality and major morbidity for lung cancer resection
Abstract
Background: The aim of this study is to create models for perioperative risk of lung cancer resection using the STS GTDB (Society of Thoracic Surgeons General Thoracic Database).
Methods: The STS GTDB was queried for all patients treated with resection for primary lung cancer between January 1, 2002 and June 30, 2008. Three separate multivariable risk models were constructed (mortality, major morbidity, and composite mortality or major morbidity).
Results: There were 18,800 lung cancer resections performed at 111 participating centers. Perioperative mortality was 413 of 18,800 (2.2%). Composite major morbidity or mortality occurred in 1,612 patients (8.6%). Predictors of mortality include the following: pneumonectomy (p < 0.001), bilobectomy (p < 0.001), American Society of Anesthesiology rating (p < 0.018), Zubrod performance status (p < 0.001), renal dysfunction (p = 0.001), induction chemoradiation therapy (p = 0.01), steroids (p = 0.002), age (p < 0.001), urgent procedures (p = 0.015), male gender (p = 0.013), forced expiratory volume in one second (p < 0.001), and body mass index (p = 0.015).
Conclusions: Thoracic surgeons participating in the STS GTDB perform lung cancer resections with a low mortality and morbidity. The risk-adjustment models created have excellent performance characteristics and identify important predictors of mortality and major morbidity for lung cancer resections. These models may be used to inform clinical decisions and to compare risk-adjusted outcomes for quality improvement purposes.
2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Predictors of prolonged length of stay after lobectomy for lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk-adjustment model.Ann Thorac Surg. 2008 Jun;85(6):1857-65; discussion 1865. doi: 10.1016/j.athoracsur.2008.03.024. Ann Thorac Surg. 2008. PMID: 18498784
-
Predictors of major morbidity and mortality after pneumonectomy utilizing the Society for Thoracic Surgeons General Thoracic Surgery Database.Ann Thorac Surg. 2010 Sep;90(3):927-34; discussion 934-5. doi: 10.1016/j.athoracsur.2010.05.041. Ann Thorac Surg. 2010. PMID: 20732520
-
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery.Ann Thorac Surg. 2009 Jul;88(1 Suppl):S23-42. doi: 10.1016/j.athoracsur.2009.05.056. Ann Thorac Surg. 2009. PMID: 19559823
-
In elderly patients with lung cancer is resection justified in terms of morbidity, mortality and residual quality of life?Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1015-21. doi: 10.1510/icvts.2010.233189. Epub 2010 Mar 30. Interact Cardiovasc Thorac Surg. 2010. PMID: 20354037 Review.
-
[Preoperative estimation of the risk of lung resection].Arch Bronconeumol. 2011;47 Suppl 3:2-4. doi: 10.1016/S0300-2896(11)70021-7. Arch Bronconeumol. 2011. PMID: 21640285 Review. Spanish.
Cited by
-
Prediction models for postoperative pulmonary complications in intensive care unit patients after noncardiac thoracic surgery.BMC Pulm Med. 2024 Aug 29;24(1):420. doi: 10.1186/s12890-024-03153-z. BMC Pulm Med. 2024. PMID: 39210309 Free PMC article.
-
Analysis of risk factors of postoperative complication for non-small cell lung cancer.BMC Pulm Med. 2024 Jul 10;24(1):333. doi: 10.1186/s12890-024-03054-1. BMC Pulm Med. 2024. PMID: 38987733 Free PMC article.
-
The risk analysis index is an independent predictor of outcomes after lung cancer resection.PLoS One. 2024 May 16;19(5):e0303281. doi: 10.1371/journal.pone.0303281. eCollection 2024. PLoS One. 2024. PMID: 38753607 Free PMC article.
-
Is the Validity of Logistic Regression Models Developed with a National Hospital Database Inferior to Models Developed from Clinical Databases to Analyze Surgical Lung Cancers?Cancers (Basel). 2024 Feb 9;16(4):734. doi: 10.3390/cancers16040734. Cancers (Basel). 2024. PMID: 38398124 Free PMC article.
-
Metformin alleviates bevacizumab-induced vascular endothelial injury in mice through growth differentiation factor 15 upregulation.Iran J Basic Med Sci. 2024;27(3):343-351. doi: 10.22038/IJBMS.2023.72759.15827. Iran J Basic Med Sci. 2024. PMID: 38333748 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
